Annual Cash & Cash Equivalents
$113.69 M
-$42.01 M-26.98%
December 31, 2023
Summary
- As of February 8, 2025, FGEN annual cash & cash equivalents is $113.69 million, with the most recent change of -$42.01 million (-26.98%) on December 31, 2023.
- During the last 3 years, FGEN annual cash & cash equivalents has fallen by -$564.71 million (-83.24%).
- FGEN annual cash & cash equivalents is now -83.24% below its all-time high of $678.39 million, reached on December 31, 2020.
Performance
FGEN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$131.00 M
-$9.71 M-6.90%
September 30, 2024
Summary
- As of February 8, 2025, FGEN quarterly cash and cash equivalents is $131.00 million, with the most recent change of -$9.71 million (-6.90%) on September 30, 2024.
- Over the past year, FGEN quarterly cash and cash equivalents has stayed the same.
- FGEN quarterly cash and cash equivalents is now -80.69% below its all-time high of $678.39 million, reached on December 31, 2020.
Performance
FGEN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
FGEN Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.0% | 0.0% |
| 3 y3 years | -83.2% | 0.0% |
| 5 y5 years | +27.4% | 0.0% |
FGEN Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.6% | at low | -30.5% | +115.4% |
| 5 y | 5-year | -83.2% | at low | -80.7% | +115.4% |
| alltime | all time | -83.2% | +192.5% | -80.7% | +115.4% |
FibroGen Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $131.00 M(-6.9%) |
| Jun 2024 | - | $140.71 M(+33.1%) |
| Mar 2024 | - | $105.73 M(-7.0%) |
| Dec 2023 | $113.69 M(-27.0%) | $113.69 M(+86.9%) |
| Sep 2023 | - | $60.81 M(-60.1%) |
| Jun 2023 | - | $152.59 M(-19.1%) |
| Mar 2023 | - | $188.55 M(+21.1%) |
| Dec 2022 | $155.70 M(-9.1%) | $155.70 M(-0.2%) |
| Sep 2022 | - | $155.96 M(-7.0%) |
| Jun 2022 | - | $167.76 M(-9.8%) |
| Mar 2022 | - | $185.90 M(+8.6%) |
| Dec 2021 | $171.22 M(-74.8%) | $171.22 M(-37.6%) |
| Sep 2021 | - | $274.53 M(-22.3%) |
| Jun 2021 | - | $353.36 M(-18.5%) |
| Mar 2021 | - | $433.51 M(-36.1%) |
| Dec 2020 | $678.39 M(+437.3%) | $678.39 M(+27.4%) |
| Sep 2020 | - | $532.47 M(+24.0%) |
| Jun 2020 | - | $429.27 M(+253.1%) |
| Mar 2020 | - | $121.56 M(-3.7%) |
| Dec 2019 | $126.27 M | $126.27 M(-35.8%) |
| Sep 2019 | - | $196.59 M(+163.6%) |
| Jun 2019 | - | $74.59 M(-8.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $81.67 M(-8.5%) |
| Dec 2018 | $89.26 M(-86.8%) | $89.26 M(-84.3%) |
| Sep 2018 | - | $566.72 M(-12.0%) |
| Jun 2018 | - | $643.80 M(-2.3%) |
| Mar 2018 | - | $659.01 M(-2.2%) |
| Dec 2017 | $673.66 M(+287.6%) | $673.66 M(+3.4%) |
| Sep 2017 | - | $651.37 M(+124.4%) |
| Jun 2017 | - | $290.28 M(+70.2%) |
| Mar 2017 | - | $170.60 M(-1.8%) |
| Dec 2016 | $173.78 M(+13.3%) | $173.78 M(-12.4%) |
| Sep 2016 | - | $198.28 M(+4.1%) |
| Jun 2016 | - | $190.41 M(+35.1%) |
| Mar 2016 | - | $140.96 M(-8.1%) |
| Dec 2015 | $153.32 M(-7.3%) | $153.32 M(-26.5%) |
| Sep 2015 | - | $208.65 M(-11.8%) |
| Jun 2015 | - | $236.54 M(+84.3%) |
| Mar 2015 | - | $128.37 M(-22.4%) |
| Dec 2014 | $165.46 M(+116.8%) | $165.46 M(+7.5%) |
| Sep 2014 | - | $153.89 M(-15.8%) |
| Jun 2014 | - | $182.66 M(+139.3%) |
| Dec 2013 | $76.33 M(+96.4%) | $76.33 M |
| Dec 2012 | $38.87 M | - |
FAQ
- What is FibroGen annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for FibroGen?
- What is FibroGen annual cash & cash equivalents year-on-year change?
- What is FibroGen quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for FibroGen?
- What is FibroGen quarterly cash and cash equivalents year-on-year change?
What is FibroGen annual cash & cash equivalents?
The current annual cash & cash equivalents of FGEN is $113.69 M
What is the all time high annual cash & cash equivalents for FibroGen?
FibroGen all-time high annual cash & cash equivalents is $678.39 M
What is FibroGen annual cash & cash equivalents year-on-year change?
Over the past year, FGEN annual cash & cash equivalents has changed by -$42.01 M (-26.98%)
What is FibroGen quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of FGEN is $131.00 M
What is the all time high quarterly cash and cash equivalents for FibroGen?
FibroGen all-time high quarterly cash and cash equivalents is $678.39 M
What is FibroGen quarterly cash and cash equivalents year-on-year change?
Over the past year, FGEN quarterly cash and cash equivalents has changed by $0.00 (0.00%)